NCT07502716Available不适用
Compassionate Use of Ubamatamab
适应症
试验速览
- 阶段
- 不适用
- 状态
- Available
研究概览
简要总结
Provide Compassionate Use of Ubamatamab
详细描述
Compassionate Use requests are only being considered in response to Individual Patient Investigational New Drug (IND) applications.
研究设计
- 研究类型
- Expanded Access
入排标准
- 接受健康志愿者
- 否
入选标准
- •Eligibility will be determined during the application review process.
排除标准
- 未提供
研究者
相似试验
招募中
1 期
Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell LymphomasNCT07278856City of Hope Medical Center20
招募中
4 期
Comparison of Mirabegron and Tamsulosin for Ureteral Stone ExpulsionUreteral CalculiNCT07310797Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation500
招募中
2 期
Phase II Trial of Amivantamab Plus Monochemotherapy in Platinum Unfit NSCLC Patients With EGFR exon20 Insertion Mutations.NCT07392658Fondazione Ricerca Traslazionale33
招募中
2 期
The Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy as the First-line Treatment for Esophageal Squamous Cell CarcinomaNCT07290010Hebei Medical University Fourth Hospital25
尚未招募
不适用
Real-World Effectiveness and Safety of Glofitamab in Primary Refractory and Early Relapsed Diffuse Large B-Cell LymphomaNCT07472621Henan Cancer Hospital20